Human irak-2, a human interleukin-1 receptor associated kinase-2
CA 2311610 A1 · Owner: Muzio, Marta · Inventors: Muzio, Marta; Ni, Jian; Dixit, Vishva M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a novel IRAK-2 protein which is a member of the IL-1 signaling pathway. In particular isolated nucleic acid molecules are , provided encoding the human IRAK-2 protein. IRAK-2 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. Also provided are diagnostic methods for detecting IRAK-2 related disorders and therapeutic methods for treating IRAK-2 related disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 25, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 25, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 25, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.